Advances in Cancer Immunotherapy™-San Francisco, CA

Society for Immunotherapy of Cancer's (SITC) Tumor Immunology 101: A Navigation Guide for the Growing Field of Cancer Immunotherapy program, part of the Advances in Cancer Immunotherapy™ series, is specifically designed for clinical oncologists, registered nurses, nurse practitioners, and the entire medical team involved in treating cancer patients with immunotherapy. These introductory, CME- and CNE-certified programs will provide an understanding of basic immunology principles in the clinical application and management of cancer immunotherapy and discuss emerging drugs and concepts in the cancer immunotherapy field.
+ show speakers and program
Program Planning Committee

Asim Amin, MD, PhD – Levine Cancer Institute Carolinas Medical Center
Matthew M. Burke, MBA, RN, MSN, APRN-B – Smilow Cancer Hospital at Yale-New Haven
Joseph W. Fay, MD – Baylor University Medical Center
Keith L. Knutson, PhD – Vaccine & Gene Therapy Institute of Florida
Hideho Okada, MD, PhD – University of California San Francisco
John D. Powderly II, MD, CPI – Carolina BioOncology Institute, PLLC
Brian I. Rini, MD – Cleveland Clinic Taussig Cancer Center
Alexander Spira, MD, PhD – Virginia Cancer Specialists
Laura S. Wood, RN, MSN, OCN – Cleveland Clinic Taussig Cancer Center

Adil Daud, MD – University of California San Francisco
Lawrence Fong, MD – University of California San Francisco
Antoni Ribas, MD, PhD – University of California San Francisco

Topics: Immunology 101 for the Non-Immunologist, Basic Principles of Tumor Immunotherapy, Basic Mechanisms of Tumor Immune Suppression, Cytokines: Interferons, Interleukins and Beyond, Understanding Checkpoint Inhibitors: Approved Agents, Drugs in Development and Combination Strategies, Oncolytic Viruses as Tumor Immunotherapy Agents, Current Status of Chimeric and Adoptive T Cell Therapy, Is There a Role for Radiation Therapy and Immunotherapy?

18 Nov - 18 Nov 2015

San Francisco
United States of America
meeting website